Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Guenter, S; Gorkiewicz, G; Halwachs, B; Kashofer, K; Thueringer, A; Wurm, P; Zollner-Schwetz, I; Valentin, T; Prattes, J; Wunsch, S; Ullrich, E; Zurl, C; Hoenigl, M; Krause, R.
Impact of ITS-Based Sequencing on Antifungal Treatment of Patients with Suspected Invasive Fungal Infections.
J Fungi (Basel). 2020; 6(2):
Doi: 10.3390/jof6020043
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Krause Robert
- Co-Autor*innen der Med Uni Graz
-
Gorkiewicz Gregor
-
Halwachs-Wenzl Bettina
-
Hönigl Martin
-
Kashofer Karl
-
König Elisabeth
-
Prattes Jürgen
-
Valentin Thomas
-
Wunsch Stefanie
-
Wurm Philipp
-
Zollner-Schwetz Ines
-
Zurl Christoph Johann
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Molecular techniques including the sequencing of fungal-specific DNA targets are increasingly used in the diagnosis of suspected invasive fungal infections. In contrast to established biomarkers like galactomannan or 1-3-β-d-glucan, the clinical impact of these methods remains unknown. We retrospectively investigated the impact of ITS1-sequencing on antifungal treatment strategies in 71 patients (81 samples) with suspected invasive fungal infections. ITS-sequencing either confirmed already ongoing antifungal therapy (19/71 patients, 27%), led to a change in antifungal therapy (11/71, 15%) or supported the decision to withhold antifungal treatment (34/71, 48%) (in seven of 71 patients, ITS-sequencing results were obtained postmortem). ITS-sequencing results led to a change in antifungal therapy in a relevant proportion of patients, while it confirmed therapeutic strategies in the majority. Therefore, ITS-sequencing was a useful adjunct to other fungal diagnostic measures in our cohort.
- Find related publications in this database (Keywords)
-
invasive fungal infections
-
ITS-sequencing
-
antifungal therapy